At what enterprise value was KERSIA acquired in 2020?

During the acquisition of KERSIA by IK PARTNERS in 2020, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of KERSIA when it was acquired by IK PARTNERS?

The estimated EV/EBITDA multiple for KERSIA is in the range of 15x - 25x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was KERSIA acquired by IK PARTNERS?

KERSIA was acquired by IK PARTNERS in 2020.

What was the revenue of KERSIA at the time of the deal?

The revenue of KERSIA at the time of the deal is estimated to be in the range of 250M - 500M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of KERSIA during the acquisition?

KERSIA's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the KERSIA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the KERSIA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.kersia-group.com/fr-ch/blog/2020/10/12/ik-investment-partners-entre-en-negociations-exclusives-avec-ardian-en-vue-de-lacquisition-de-kersia/

← DATABASE

Home Database Healthcare & PharmaKERSIA

10/2020

KERSIA acquired by IK PARTNERS

FRANCE Healthcare Services / Sterilization & Hygiene EV 1b - 4b EUR

Context

IK Investment Partners acquired a majority stake in Kersia from Ardian. This transaction was initiated through exclusive negotiations via the IK IX fund, marking the first deal for this specific vehicle. The investment strategy is focused on supporting the group through its next phase of growth and continuing an active global sector consolidation policy. The project builds on the target's remarkable trajectory, having tripled in size in less than four years through the successive integration of six specialized companies. The new shareholder intends to capitalize on the group's technological expertise and extensive geographical presence to reinforce its leadership in the food safety sector. The transaction also allows the historical shareholder to realize the value created while passing the baton to a partner experienced in supporting high-growth industrial leaders.

KERSIA, which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Kersia is a global leader in food safety. It provides end-to-end solutions for preventing diseases and contamination in both animals and humans throughout the entire food supply chain. The group develops, manufactures, and sells a wide range of hygiene and disinfection solutions for the farming and food processing industries. With a strong commitment to sustainable development, the firm integrates ecological products into its core offering to meet increasing regulatory and consumer demands. Following multiple strategic acquisitions, the group has scaled its operations significantly, employing nearly 1,800 people worldwide. Its expertise spans from farm-level biosecurity to advanced Corporate hygiene for food manufacturing plants, positioning the firm as a global reference for food safety and environmental protection.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Other operations with KERSIA

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
04/2025	KERSIA	NEOGEN (ANIMAL BIOSECURITY DIVISION)	UNITED STATES	Sterilization & Hygiene
11/2020	KERSIA	SOPURA	BELGIUM	Sterilization & Hygiene

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 250M - 500M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of KERSIA by IK PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: kersia

Acquirer: ik partners